Hepatocellular carcinoma

被引：511

作者：

Schafer, DF ^{[1
]}

Sorrell, MF ^{[1
]}

机构：

[1] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE USA

来源：

LANCET | 1999年 / 353卷 / 9160期

关键词：

D O I：

10.1016/S0140-6736(98)09148-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival Is rare. However, the major causes of HCC worldwide are known and preventable. Hepatitis B and C exist only in man; the viruses have no known non-human reservoirs. Transmission of the viruses can be interrupted by vaccination against hepatitis B virus infection acid improvements in medical techniques for hepatitis C; for which no vaccine has yet been developed.

引用

页码：1253 / 1257

页数：5

共 67 条

[1] LIVER-CELL DYSPLASIA - PREMALIGNANT CONDITION [J].

ANTHONY, PP ;

VOGEL, CL ;

BARKER, LF .

JOURNAL OF CLINICAL PATHOLOGY, 1973, 26 (03) :217-223

[2]

AUSTIN H, 1991, ETIOLOGY PATHOLOGY T

[3]

BEASLEY RP, 1981, LANCET, V2, P1129

[4]

BEEBE GW, 1991, ADV AP BIOT, V13, P3

[5] BLOOD-SUPPLY OF EARLY HEPATOCELLULAR-CARCINOMA [J].

BHATTACHARYA, S ;

DAVIDSON, B ;

DHILLON, AP .

SEMINARS IN LIVER DISEASE, 1995, 15 (04) :390-401

[6]

Bismuth H, 1993, Prog Liver Dis, V11, P269

[7]

BOSCH FX, 1997, LIVER CANCER, P13

[8]

Bruix J, 1997, HEPATOLOGY, V25, P259

[9] TREATMENT OF HEPATOCELLULAR-CARCINOMA WITH TAMOXIFEN - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL IN 120 PATIENTS [J].

CASTELLS, A ;

BRUIX, J ;

BRU, C ;

AYUSO, C ;

ROCA, M ;

BOIX, L ;

VILANA, R ;

RODES, J .

GASTROENTEROLOGY, 1995, 109 (03) :917-922

[10] Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children [J].

Chang, MH ;

Chen, CJ ;

Lai, MS ;

Hsu, HM ;

Wu, TC ;

Kong, MS ;

Liang, DC ;

Shau, WY ;

Chen, DS .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) :1855-1859

← 1 2 3 4 5 6 7 →